CD79A and precursor B-cell acute lymphoblastic leukemia: It has been reported that the specific IgA to murine scFv of FMC63 could be detected in sera of B-ALL patients received mCD19 CAR-T, and the existence of murine CAR-specific IgA may render the second mCD19 CAR-T treatment ineffective [9].